Medicare Enrolled
Dr. Jason Starr, DO
Hematology & Oncology · Jacksonville, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Starr from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Starr?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Starr
Dr. Jason Starr is a hematology & oncology specialist in Jacksonville, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Starr performed 27,516 Medicare services across 1,617 unique beneficiaries.
Between the years covered by Open Payments, Dr. Starr received a total of $22,566 from 15 pharmaceutical and/or device companies across 32 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Starr is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 21% volume in FL
$22,566 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 10884 | Clear | March 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗27,516
Medicare services
Top 21% in FL for hematology & oncology
1,617
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,619 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nivolumab injection (Opdivo) | 5,500 | $24 | $114 |
| Pembrolizumab injection (Keytruda) | 5,400 | $43 | $204 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
5,100 | $0 | $1 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
2,340 | $37 | $188 |
| Paclitaxel chemotherapy injection | 1,788 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 1,500 | $18 | $90 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
1,030 | $36 | $136 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
998 | $0 | $4 |
| Anti-nausea injection (ondansetron/Zofran) | 780 | $0 | $5 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
595 | $5 | $9 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
294 | $138 | $604 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
241 | $12 | $219 |
| Anti-nausea injection (Aloxi/palonosetron) | 240 | $1 | $7 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
148 | $100 | $869 |
| Injection, leucovorin calcium, per 50 mg | 143 | $3 | $21 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 122 | $3 | $37 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
115 | $2 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
113 | $91 | $450 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
97 | $2 | $33 |
| New patient office visit, complex (60-74 min) | 95 | $163 | $891 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
92 | $20 | $135 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
71 | $11 | $102 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 66 | $134 | $692 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
64 | $2 | $82 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
60 | $10 | $114 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
59 | $22 | $233 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
53 | $50 | $446 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
42 | $22 | $212 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
39 | $55 | $352 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
39 | $1 | $38 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
34 | $48 | $426 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
34 | $26 | $200 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
33 | $16 | $154 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
26 | $1 | $77 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $134 | $707 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
24 | $26 | $121 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
23 | $18 | $96 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
22 | $28 | $600 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $68 | $296 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
18 | $25 | $345 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
17 | $15 | $143 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
17 | $133 | $993 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.4% high complexity
91.7% medium
2.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,566
Total received (2018-2024)
Avg $3,224/year across 7 years
Top 24% in FL for hematology & oncology
15
Companies
32
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$18,825 (83.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,089 (13.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$652 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,290
2023
$217
2022
$641
2021
$13,744
2020
$5,354
2019
$260
2018
$59
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Ipsen Biopharmaceuticals, Inc
$4,904
Taiho Oncology, Inc.
$4,338
TerSera Therapeutics LLC
$3,974
Helsinn Therapeutics (U.S.), Inc.
$2,655
ARRAY BIOPHARMA INC
$2,520
Exelixis Inc.
$2,230
Advanced Accelerator Applications
$1,485
Genentech USA, Inc.
$125
Lexicon Pharmaceuticals, Inc.
$107
Bayer Healthcare Pharmaceuticals Inc.
$80
Novartis Pharmaceuticals Corporation
$56
Foundation Medicine, Inc.
$28
Tempus AI, Inc
$28
Deciphera Pharmaceuticals Inc.
$25
Gilead Sciences, Inc.
$12
Top 3 companies account for 58.6% of total payments
Associated products mentioned in payments ›
Avastin · BRAFTOVI · CABOMETYX · FOUNDATIONONE · INQOVI · LUTATHERA · Lonsurf · Onivyde · QINLOCK · SOMATULINE DEPOT · Stivarga · TRUSELTIQ · Xermelo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (83%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $82 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
104
Per 100K population
10.3
County median income
$68,447
Nearest hospital
MAYO CLINIC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Starr is a mixed practice specialist, with above-average Medicare volume (top 21% in FL), with consulting-driven industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Starr experienced with nivolumab injection (opdivo)?
Based on Medicare claims data, Dr. Starr performed 5,500 nivolumab injection (opdivo) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Starr receive payments from pharmaceutical companies?
Yes. Dr. Starr received a total of $22,566 from 15 companies across 32 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Starr's costs compare to other hematology & oncology specialists in Jacksonville?
Dr. Starr's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Starr) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Jacksonville
Browse hematology & oncology specialists in Jacksonville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Ipsen Biopharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Ipsen Biopharmaceuticals, Inc.
By company
Taiho Oncology, Inc. Payments to Doctors
See all physicians who received payments from Taiho Oncology, Inc.
By company
TerSera Therapeutics LLC Payments to Doctors
See all physicians who received payments from TerSera Therapeutics LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology